Results 71 to 80 of about 4,363 (145)

Impact of Śodhana (Ayurvedic purification process) on thrombolytic effect of Semecarpus anacardium Linn. f. Nut

open access: yesAncient Science of Life, 2017
Aims and Objectives: In vitro evaluation and comparison of thrombolytic activity of raw and purified bhallātaka (Semecarpus anacardium Linn.f.) nuts by means of % of clot lysis.
Dattatray D Sarvade   +2 more
doaj   +1 more source

Anti-streptokinase antibody inhibition of streptokinase induced fibrinolysis following intra-pleural streptokinase

open access: yes, 2016
Background. Anti-streptokinase immunoglobulin (IgG) induced by intravenous (IV) streptokinase (SK) can reduce the effectiveness of repeated SK use, or lead to an increased incidence of immune mediated adverse reactions. It is therefore advised that IV SK

core  

Anaphylactic Reaction to Streptokinase with First Exposure: Case Report and Review of the Literature

open access: yes, 1989
Thrombolytic therapy has become an accepted part of the management of acute myocardial infarction. One agent with widespread use in this setting is streptokinase.
Susan C. Sherlock   +3 more
core   +1 more source

Evaluation of Streptokinase Production Potential by Group C Streptococcal Strain H46A in Batch Culture and Bactericidal Effect of Hexyl Resorcinol

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2009
BACKGROUND AND OBJECTIVE: Streptokinase (SK) is a microbial plasminogen-activator that is used in the treatments, especially at Acute ischemic stroke, declotting of dialysis shunts and inflammatory antibiotic-resistant prostatitis.
MR Nejadmoghaddam,   +2 more
doaj  

The role of humoral mediators in immunological reactions to streptokinase [PDF]

open access: yes, 1995
Streptokinase is now a commonly administered thrombolytic agent in AMI patients. One of the main disadvantages of its administration is that as a foreign antigen it may provoke hypersensitivity reactions due to previous streptococcal infections, and' pre-
Afshari, Afshin
core   +1 more source

Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction

open access: yes, 1990
SUMMARY A patient developed serum sickness and acute renal failure following therapy with streptokinase for myocardial ischaemia. There was a previous history of a cellulitic infection of the leg.
C G WINEARLS   +4 more
core   +1 more source

Clinical effects of Streptokinase in acute myocardial infarction

open access: yes, 2003
Background: With respect to the efficacy of thrombolytic agents in the treatment of acute myocardial infarction, the present study was conducted on CCU patients in Shaheed Beheshti hospital in Kashan in 1999-2000.
Abdar Esfahani, M.   +3 more
core  

Door to Needle Time and its Impact on Successful Thrombolysis

open access: yesJournal of Rawalpindi Medical College, 2012
Background: To evaluate the Door to needle time and its impact on successful thrombolysis . Methods : In this cross sectional study all patients admitted with Acute Myocardial Infarction (AMI), who were candidates for fibrinolysis, were included ...
Sarfaraz Ali Zahid
doaj  

Influence of adenylic nucleotides on the activating function of streptokinase

open access: yes, 1987
The addition of ATP or 3,5-AMP (but not UTP, GTP, CTP, AMP, 2,3-AMP, ADP, inorganic pyrophosphate) at a final concentration of 10 - 1 M into streptokinase solution, pH 7.0 or 9.5, causes a dramatical inhibition of streptokinase-induced fibrinolysis.
Пыжова, Н.С.   +5 more
core  

Multiple Exosites Distributed across the Three Domains of Streptokinase Co-Operate to Generate High Catalytic Rates in the Streptokinase–Plasmin Activator Complex

open access: yes, 2016
To examine the global function of the key surface-exposed loops of streptokinase, bearing substrate-specific exosites, namely, the 88–97 loop in the α domain, the 170 loop in the β domain, and the coiled-coil region (Leu321-Asn338) in the γ domain ...
Girish Sahni (1872853)   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy